Effect of the glutathione-depleting agents diethylmaleate, phorone and buthionine sulfoximine on biliary copper excretion in rats.
The involvement of glutathione (GSH) in the biliary excretion of Cu was investigated in bile-cannulated inbred WAG/Rij and BN rats, pretreated with diethylmaleate (DEM), phorone or buthionine sulfoximine (BSO) and injected with Cu doses of 10 or 30 micrograms/100 g body wt. DEM reduced liver GSH to 27-56% and biliary GSH excretion to 18-38%; phorone reduced GSH in the liver to 55% and increased it in the bile (113%) followed by a slight decrease (79%); BSO reduced liver GSH to 50% and bile GSH to 20%. After injection of Cu to control rats a profile of biliary Cu excretion was found, composed of a slowly (SCuE) and a rapidly (RCuE) disappearing component, the latter only present after the dose of 30 micrograms Cu. DEM had no effect on SCuE after a 10 micrograms dose and a temporary effect on SCuE after a 30 micrograms dose in both WAG/Rij and BN rats. Phorone reduced SCuE after both Cu doses to 50%. Both agents abolished RCuE and reduced endogenous biliary Cu excretion to less than 50%. Release of injected Cu from plasma and uptake by the liver was inhibited by DEM and phorone in both rat strains; in BN rats basal plasma Cu level of DEM-treated rats was increased as well. BSO reduced SCuE after both Cu doses but had no influence on RCuE. Endogenous Cu excretion was reduced by BSO in BN rats but not in WAG/Rij rats. The results show that biliary Cu excretion proceeds by a pattern, the components of which can be affected differently by the various drugs. They also indicate that GSH is not directly involved in biliary Cu excretion but suggest that it may play a role in the metabolism of Cu in the liver.